Hemab Therapeutics Holdings, Inc. (COAG)

Hemab Therapeutics Holdings, Inc. (COAG) is a healthcare company (biotechnology) based in the United States. The share price is $39.05, down 0.01% on the day, which values the company at $1.82B. Price as of 17 Nov 2026, 20:58 UTC, from Yahoo Finance.

Key facts

Share price
$39.05−0.01% today
Market value
$1.82B
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Hemab Therapeutics Holdings, Inc. in more detail

COAG trades at -14.7× next year's expected earnings.

In its favour: More cash than debt.

1 of the superinvestors tracked here hold COAG, including Peter Kolchinsky (2.5% of the portfolio).

Superinvestors holding COAG

1 of the investors tracked here report a position in their latest 13F filing.

Hemab Therapeutics Holdings, Inc. (COAG): questions and answers

What is Hemab Therapeutics Holdings, Inc.'s market cap?

Hemab Therapeutics Holdings, Inc. is valued at $1.82B at a share price of $39.05.

Does COAG pay a dividend?

Hemab Therapeutics Holdings, Inc. does not currently pay a regular dividend.

Which famous investors own COAG?

In their latest quarterly filings, Peter Kolchinsky (2.5% of the portfolio) hold COAG. These filings are published up to 45 days after each quarter ends, so positions may have changed since.

Cite this page

Funkfolio, “Hemab Therapeutics Holdings, Inc. (COAG) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/COAG

Underlying data: Yahoo Finance; company filings with the SEC.